Literature DB >> 17103449

Sudden infant death in a patient with FGFR3 P250R mutation.

P S Shah1, K Siriwardena, G Taylor, L Steele, P Ray, S Blaser, D Chitayat.   

Abstract

P250R mutation in the FGFR3 gene also known as Muenke syndrome is associated with coronal craniosynostosis, sensorineural deafness, craniofacial, and digital abnormalities. We report a family with this mutation associated with sudden death in an affected newborn, most probably due to upper airway obstruction. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103449     DOI: 10.1002/ajmg.a.31517

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  Hearing loss in syndromic craniosynostoses: introduction and consideration of mechanisms.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Maximilian Muenke
Journal:  Am J Audiol       Date:  2014-06       Impact factor: 1.493

Review 2.  Epilepsy in Muenke syndrome: FGFR3-related craniosynostosis.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Andrea L Gropman; Maximilian Muenke
Journal:  Pediatr Neurol       Date:  2012-11       Impact factor: 3.372

3.  Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.

Authors:  Jin Liu; Hwa Kyung Nam; Estee Wang; Nan E Hatch
Journal:  Calcif Tissue Int       Date:  2013-01-29       Impact factor: 4.333

4.  Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.

Authors:  Jin Liu; Hwa Kyung Nam; Cassie Campbell; Kellen Cristina da Silva Gasque; José Luis Millán; Nan E Hatch
Journal:  Bone       Date:  2014-07-09       Impact factor: 4.398

5.  Craniosynostosis-associated Fgfr2(C342Y) mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation.

Authors:  J Liu; T-G Kwon; H K Nam; N E Hatch
Journal:  Biomed Res Int       Date:  2013-05-09       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.